valecobulin (CKD-516) / Chong Kun Dang  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
valecobulin (CKD-516) / Chong Kun Dang
NCT01028859: Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Completed
1
30
RoW
CKD-516 inj, CKD-516
Chong Kun Dang Pharmaceutical, Seoul National University Hospital
Unspecified Adult Solid Tumor, Protocol Specific
04/11
04/11
NCT01560325: Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Completed
1
21
RoW
CKD-516 inj., CKD-516
Chong Kun Dang Pharmaceutical
Unspecified Adult Solid Tumor, Protocol Specific
10/14
10/14
NCT02300467: NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors

Unknown status
1
30
RoW
NOV120401, CKD-516 Tablet
National OncoVenture, Chong Kun Dang Pharmaceutical
Advanced Refractory Solid Tumors
07/16
07/16

Download Options